- Home
- CLNN vs INO Comparison
CLNN vs INO Comparison
Compare CLNN & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLNN | INO |
|---|---|---|
| Founded | 2012 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 116.1M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | CLNN | INO |
|---|---|---|
| Price | $5.16 | $1.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $32.67 | $9.00 |
| AVG Volume (30 Days) | 96.2K | ★ 2.3M |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $214,000.00 | $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $92.84 | $21,214.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.28 | $1.30 |
| 52 Week High | $13.50 | $2.98 |
Technical Indicators
Market Signals| Indicator | CLNN | INO |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 39.67 |
| Support Level | $4.50 | $1.50 |
| Resistance Level | $6.68 | $1.72 |
| Average True Range (ATR) | 0.61 | 0.12 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 31.06 | 17.71 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.